White Paper
Mesalamine’s complex pharmacokinetics and low absorption make bioequivalence studies particularly challenging. Advity Research navigated these hurdles with optimized study designs, advanced analytics, and meticulous execution—delivering reliable resul
White Paper
Delays in trial startup slow innovation and keep life-saving treatments from patients who need them most. This whitepaper explores the root causes of startup bottlenecks—regulatory hurdles, site delays, contracting inefficiencies—and outlines proven,
White Paper
Weak reporting systems, limited resources, and cultural barriers continue to hinder drug safety monitoring in developing countries. This article explores the core challenges affecting adverse drug reaction reporting and outlines the key drivers—technolo
White Paper
Strategic site selection is the backbone of successful clinical trials—impacting data quality, timelines, recruitment, and overall trial efficiency. This whitepaper explores a systematic, evidence-driven framework for evaluating and selecting high-perfo